Candida albicans can foster gut dysbiosis and systemic inflammation during HIV infection

SD Zaongo, J Ouyang, S Isnard, X Zhou… - Gut …, 2023 - Taylor & Francis
Candida albicans (C. albicans) is a ubiquitous fungal commensal component of the human
microbiota, and under certain circumstances, such as during an immunocompromised state …

Role of vaginal mucosa, host immunity and microbiota in vulvovaginal candidiasis

SN Balakrishnan, H Yamang, MC Lorenz, SY Chew… - Pathogens, 2022 - mdpi.com
Vulvovaginal candidiasis (VVC) is a prevalent gynaecological disease characterised by
vaginal wall inflammation that is caused by Candida species. VVC impacts almost three …

The prevalence, etiological agents, clinical features, treatment, and diagnosis of HIV-associated oral candidiasis in pediatrics across the world: a systematic review …

Z Rafat, E Sasani, Y Salimi, S Hajimohammadi… - Frontiers in …, 2021 - frontiersin.org
In HIV-infected pediatrics, oral candidiasis (OC) is a global issue of concern due to its
association with dysphagia, malnutrition, and mortality. The present systematic review and …

Fungal and bacterial co-infections of the respiratory tract among patients with COVID-19 hospitalized in intensive care units

Z Rafat, A Ramandi, PA Khaki, S Ansari… - Gene reports, 2022 - Elsevier
Backgrounds The pandemic of COVID-19 has created a global public health crisis. ICU
patients with COVID-19 are prone to infections of bacterial and/or fungal origins due to …

Prevalence, antifungal susceptibility and etiology of vulvovaginal candidiasis in sub–Saharan Africa: A systematic review with meta-analysis and meta-regression

MF Mushi, R Olum, F Bongomin - Medical Mycology, 2022 - academic.oup.com
Vulvovaginal candidiasis (VVC) is a commonly occurring form of mucocutaneous
candidiasis in women. The aim of this study was to comprehensively investigate the …

Epidemiological Profile of Patients with Vulvovaginal Candidiasis from a Sexually Transmitted Infection Clinic in Southern Spain

E Martínez-García, JC Martínez-Martínez… - Pathogens, 2023 - mdpi.com
Epidemiological data on women suffering from vulvovaginal candidiasis and its recurrence
are outdated and vague. The aim of this study was to identify the prevalence of women …

[HTML][HTML] Drug resistance and biofilm formation in Candida species of vaginal origin

T Alikhani, RD Ghazvini, M Mirzaii… - Iranian Journal of …, 2022 - ncbi.nlm.nih.gov
Background: Candida species are normal vaginal flora in healthy women, which can cause
vulvovaginal candid-iasis (VVC). The formation of biofilm is a cause of drug resistance in …

Phytotherapy of Vulvovaginal Candidiasis: A Narrative Review

N Picheta, J Piekarz, O Burdan, M Satora… - International Journal of …, 2024 - mdpi.com
Vulvovaginal candidiasis (VVC) is a real gynecological problem among women of
reproductive age from 15 to 49. A recent analysis showed that 75% of women will have an …

Assessment of risk factors for developing vulvovaginal candidiasis among women at various age groups

VR Irene, CI Sajeeth, V Karthikeyan - Biosciences Biotechnology …, 2023 - biotech-asia.org
Vulvovaginal candidiasis (VVC) is the second most frequent vaginal infection in women and
occurs as an opportunistic infection generally caused by Candida albicans. The objective of …

Loop-Mediated Isothermal Amplification (LAMP): Potential Point-of-Care Testing for Vulvovaginal Candidiasis

M Li, X Jin, Q Jiang, H Wei, A Deng, Z Mao, Y Wang… - Journal of Fungi, 2023 - mdpi.com
Purpose: The aim of this study is to establish a loop-mediated isothermal amplification
(LAMP) method for the rapid detection of vulvovaginal candidiasis (VVC). Methods: We …